Over 95% of pancreatic cancers are exocrine tumors that bare a dismal prognosis. Although oncological outcome is best for patients presenting with nonmetastatic resectable disease, cure is rarely achieved . Up to 40% of patients present with nonmetastatic disease that is considered unresectable due to vascular encasement (locally advanced pancreatic carcinoma or LAPC) [1, 2]. These patients are nowadays routinely offered systemic chemotherapy with or without radiotherapy. Irreversible electroporation (IRE) represents a promising new method for focal destruction of pancreatic tumors. Evidence to support its effectiveness is gradually surfacing.
|Title of host publication||Irreversible Electroporation in Clinical Practice|
|Publisher||Springer International Publishing|
|Publication status||Published - 2017|
|Name||Irreversible Electroporation in Clinical Practice|
Meijerink, M. R., Nilsson, A., Narayanan, G., & Martin, R. (2017). Irreversible electroporation of pancreatic tumors. In Irreversible Electroporation in Clinical Practice (pp. 167-190). (Irreversible Electroporation in Clinical Practice). Springer International Publishing. https://doi.org/10.1007/978-3-319-55113-5_11